BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2009
View Archived Issues
New naturally derived antidiabetic compound preserves beta-cell function in preclinical studies
Read More
Beta-secretase inhibitors for the treatment of Alzheimer's disease disclosed by Boehringer Ingelheim
Read More
L-2286 attenuates myocardial hypertrophy in spontaneously hypertensive rats
Read More
AZD-0837 effects on fibrin D-dimer levels and pharmacokinetics correlated in phase II study
Read More
Novel angiotensin II antagonists described by Merck & Co. as antihypertensives
Read More
Roche claims c-Met inhibitors for the treatment of cancer and other conditions
Read More
Cangrelor prevents binding of clopidogrel and prasugrel active metabolites to P2Y12
Read More
Wyeth describes novel 5-HT2C receptor agonists with atypical antipsychotic activity
Read More
Gold nanoparticles developed for the diagnosis of lung cancer in breath samples
Read More
BioMS Medical and Lilly terminate license and collaboration agreement for dirucotide in MS
Read More
FDA recommends accelerated approval for Allos Therapeutics' Folotyn in PTCL
Read More
Amura Therapeutics reports results from rheumatoid arthritis study
Read More
U.S. bankruptcy court approves Cornerstone Therapeutics' acquisition of Oscient's Factive
Read More
FDA accepts for review Takeda's sNDA for Velcade in previously untreated multiple myeloma
Read More
FDA extends review period for Endo's testosterone undecanoate for hypogonadism
Read More
Alla Chem presents 5-HT6 receptor antagonists for the treatment of cognition disorders
Read More
Pharming submits new MAA to EMEA for Rhucin for acute hereditary angioedema attacks
Read More
Calcium channel blockers claimed by Cosunter as antihypertensives
Read More
Peplin to be acquired by Leo Pharma for USD 287.5 million in cash
Read More
Delta opioid receptor agonist ADL-5747 advances to phase I safety trial based on in vivo activity
Read More
Genfit and Bicoll report preliminary results from OLNORME research project
Read More
Diamyd Medical reports 4-year follow-up data from phase II study of Diamyd
Read More
MabThera approved in Europe for previously treated chronic lymphocytic leukemia
Read More
FDA approves once-daily Intuniv for ADHD
Read More
Santhera initiates phase III idebenone trial in Duchenne muscular dystrophy
Read More
Merck & Co. launches tafluprost in the U.K. and Spain for glaucoma and ocular hypertension
Read More
